BRCA2-RAD51
The use of fragment-based drug discovery to develop novel small molecules that modulate the BRCA2-RAD51 interaction for the treatment of cancer
| Coordinator | THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE |
| Grant period | 2011-03-01 - 2013-02-28 |
| Funding body | European Union |
| Call number | FP7-PEOPLE-2010-IIF |
| Grant number | 274569 |
| Identifier | G:(EU-Grant)274569 |